TWST:NASDAQ
Twist Bioscience Corp
$126.85
arrow_upward
+1.06%(+1.33) 1D
$126.85
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$121.66
High
$129.28
Low
$120.19
Mkt. cap
8.41B
Avg. vol.
1.71M
Volume
0.00
52-wk high
$155.43
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
Open
$121.66
High
$129.28
Low
$120.19
Mkt. cap
8.41B
Avg. vol.
1.71M
Volume
0.00
52-wk high
$155.43
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Stock Titan
·
3 days ago
Twist Bioscience (NASDAQ: TWST) HR chief reports tax-driven stock sale
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp